Literature DB >> 17460113

Immunization with PspA incorporated into a poly(ethylene oxide) matrix elicits protective immunity against Streptococcus pneumoniae.

Quincy C Moore1, LaShundra Johnson, Michael Repka, Larry S McDaniel.   

Abstract

CBA/N mice were immunized with PspA in a poly(ethylene oxide) matrix to examine its ability to deliver the antigen and modulate the immune response. All mice receiving PspA in the matrix survived a lethal pneumococcal challenge and had serum anti-PspA antibody levels statistically higher than mice receiving PspA alone (P < 0.009).

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17460113      PMCID： PMC1951078          DOI： 10.1128/CVI.00082-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  20 in total

1.  Pneumococcal disease and the role of conjugate vaccines.

Authors:  D L Klein
Journal:  Microb Drug Resist       Date:  1999       Impact factor: 3.431

Review 2.  Community-acquired pneumonia.

Authors:  V Gant; S Parton
Journal:  Curr Opin Pulm Med       Date:  2000-05       Impact factor: 3.155

3.  Enhanced protective immunity against pneumococcal infection with PspA DNA and protein.

Authors:  Quincy C Moore; Joseph R Bosarge; Lisa R Quin; Larry S McDaniel
Journal:  Vaccine       Date:  2006-05-04       Impact factor: 3.641

Review 4.  The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known.

Authors:  D S Fedson; J A Scott; G Scott
Journal:  Vaccine       Date:  1999-07-30       Impact factor: 3.641

5.  Characterization of cellulosic hot-melt extruded films containing lidocaine.

Authors:  Michael A Repka; Kavitha Gutta; Suneela Prodduturi; Manish Munjal; Steven P Stodghill
Journal:  Eur J Pharm Biopharm       Date:  2005-01       Impact factor: 5.571

Review 6.  Community-acquired pneumonia.

Authors:  H A Cassiere; M S Niederman
Journal:  Dis Mon       Date:  1998-11       Impact factor: 3.800

7.  Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260.

Authors:  L S McDaniel; B A Ralph; D O McDaniel; D E Briles
Journal:  Microb Pathog       Date:  1994-11       Impact factor: 3.738

Review 8.  Community-acquired pneumonia.

Authors:  J P Lynch; F J Martinez
Journal:  Curr Opin Pulm Med       Date:  1998-05       Impact factor: 3.155

9.  Production and characterization of hot-melt extruded films containing clotrimazole.

Authors:  Michael A Repka; Suneela Prodduturi; Steven P Stodghill
Journal:  Drug Dev Ind Pharm       Date:  2003-08       Impact factor: 3.225

10.  New Fluoroquinolones: Real and Potential Roles.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-12       Impact factor: 3.663
View more
  3 in total

1.  Immunization with pneumolysin protects against both retinal and global damage caused by Streptococcus pneumoniae endophthalmitis.

Authors:  Melissa E Sanders; Erin W Norcross; Quincy C Moore; Jonathan Fratkin; Hilary Thompson; Mary E Marquart
Journal:  J Ocul Pharmacol Ther       Date:  2010-10-29       Impact factor: 2.671

2.  Pneumococcal surface protein A contributes to secondary Streptococcus pneumoniae infection after influenza virus infection.

Authors:  Quinton O King; Benfang Lei; Allen G Harmsen
Journal:  J Infect Dis       Date:  2009-08-15       Impact factor: 5.226

3.  Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia.

Authors:  Daniel M Musher; Adriana M Rueda; Moon H Nahm; Edward A Graviss; Maria C Rodriguez-Barradas
Journal:  J Infect Dis       Date:  2008-10-01       Impact factor: 5.226
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.